Back to results
US 2003/0152512 A1Published application
Imaging thrombus with glycoprotein llb/llla antagonists
OwnerMilind Rajopadhye, John A. Barrettinventors
Life of this patent
Estimating the term…
Abstract
This invention relates to a method of using a radiolabeled small molecule antagonist of the platelet IIb/IIIa receptor for the diagnosis of arterial and venous thrombi.
Claims35
A method for imaging a thrombi within a mammalian body comprising contacting the thrombi with an effective amount of a radiopharmaceutical that binds to a platelet glycoprotein IIb/IIIa receptor and detecting the presence of the radiopharmaceutical;
- wherein the radiopharmaceutical has a blood clearance half-life (alpha phase) in the mammalian body of about 10 minutes to about 120 minutes.
Dependencies are inferred from the claim text.